15 research outputs found
Doce miradas del conflicto colombiano
Esta publicación es uno de los resultados de la concesión al Instituto de
estudios internacionales y europeos Francisco de Vitoria de la Universidad Carlos
III del proyecto Difusión y aplicación del Derecho internacional humanitario en
Colombia, del que ha sido Investigador Principal el Prof. Carlos R. Fernández
Liesa.Este libro es el resultado del proyecto de investigación Difusión y aplicación del Derecho internacional humanitario en Colombia, de la convocatoria CAP de la Agencia española de cooperación internacional (2012-2103) adscrito al Instituto de estudios internacionales y europeos Francisco de Vitoria de la Universidad Carlos III de Madrid. Esta edición ha contado con el apoyo de la Cátedra Iberoamericana Santander
y de la Cátedra Mario Villarroel de Derecho internacional humanitario y de
derechos humanos.Dirección de la colección, Carlos R. Fernández Liesa y Montserrat Huguet SantosEn este volumen de doce contribuciones hay cuatro de
españoles, tres catedráticos de Derecho internacional (Manuel Pérez González,
Antonio Pigrau y Carlos R. Fernández Liesa) y un Magistrado del Tribunal
Supremo, general togado, Fernando Pignatelli. Por parte colombiana han realizado
seis ponencias a cargo de profesores de Uninorte (Gabriel Orozco, Rosemary
Suárez, José Luis Ramos, Roberto González Arana, Luis Fernando Trejos, Pedro
Montero, Cecilia Giovanneti Lugo, Jessyka Manotas e Ivonne Molinero) y dos a
cargo de importantes expertos. De un lado, Armando Borrero, profesor y antiguo
Consejero de Seguridad Nacional de Colombia y, de otra, Saúl Ramírez Quesada,
Presidente del Colegio de abogados de ColombiaPalabras previas / Carlos R. Fernández Liesa. -- Impacto Humanitario de la violencia armada en Colombia / Gabriel Orozco y Rosmery Suárez. -- Impacto del conflicto armado en el desempeño económico de las regiones: el caso del Caribe colombiano / José L. Ramos R. -- Derecho internacional humanitario y derechos humanos. Reflexiones sobre el conflicto colombiano / Carlos R. Fernández Liesa. -- Tipos de conflictos y aplicación del derecho internacional humanitario, con especial referencia a los conflictos armados internacionales / Manuel Pérez González. -- La crisis del derecho en los conflictos armados confusos y desregulados / Armando Borrero Mansilla. -- Nuevas perspectivas del conflicto armado colombiano / Roberto González Arana. -- La diplomacia insurgente. Otra forma de internacionalización del conflicto armado colombiano: el caso de las FARC-EP / Luis Fernando Trejos Rosero. -- La aplicación del derecho internacional humanitario en Colombia / Saúl Ramírez Quesada. -- Derechos de las víctimas en el tránsito hacia la normalización judicial (la verdad, la justicia, la reparación y las garantías de no repetición) / Pedro Montero Linares. -- La mujer y su doble condición: víctima de los conflictos internos y protagonista en los procesos de justicia transicional. El caso de Colombia / Cecilia Giovannetti Lugo, Jessyka Manota Muñoz e Ivonne Molinares Guerrero. -- El sistema de eficacia del derecho internacional humanitario, en especial la protección penal de las víctimas en los conflictos armados internos / Fernando Pignatelli y Meca. -- Colombia: la investigación pendiente de la Corte Penal Internacional / Antoni Pigrau
Isolation of Salmonella enterica in opossum (Didelphis aurita and Didelphis albiventris) of the São Paulo State, Brazil
No Brasil, não há relato de estudos de Salmonella em gambás, sendo assim, este trabalho tem por objetivo determinar a frequência de isolamento de Salmonella enterica em gambás (D. aurita e D. albiventris) no Estado de São Paulo. No período de janeiro de 2005 a dezembro de 2006, foram necropsiados 106 D. aurita e 40 D. albiventris e colhidos fragmentos de intestinos delgado, grosso e suabe da cloaca. As amostras foram plaqueadas diretamente em ágar Mac Conkey, paralelamente suspendidas nos caldos Rappaport-Vassiliadis e Tetrationato e posteriormente plaqueados em ágar XLT4. As colônias sugestivas de Salmonella foram confirmadas através de provas bioquímicas e sorotipagem. Encontrou-se Salmonella enterica em 17,0% (18/106) dos D. aurita. Destes, 50% apresentaram positividade no intestino delgado (ID), 88,9% no intestino grosso (IG) e 66,7% na cloaca. Da espécie S. enterica, as subespécies encontradas foram: diarizonae (11,1%) houtenae e enterica (5,5% cada um); enquanto da subespécie S. enterica enterica os sorotipos foram Newport (83,3%), Typhimurium e Cerro (5,5% cada um). Nos D. albiventris, 17,5% (7/40) eram positivos, sendo que se encontraram 42,8% no ID, 85,7% no IG e 71,4% na cloaca. O sorotipo mais prevalente também foi Newport (71,4%), seguido por Typhimurium, Bareilly e Thompson (14,3% cada um). Através dos resultados obtidos neste estudo pode-se comprovar a presença de Salmonella enterica no trato intestinal de gambás no Brasil.In Brazil there is not report of Salmonella in opossum, so then, the objective of this study is to determine the isolation frequency of Salmonella enterica in opossum in São Paulo State, Brazil. From January 2005 to December 2006, 106 D. aurita and 40 D. albiventris were necropsied and samples from small and large intestine and cloacal swab were collected. These samples were submitted to direct plating in Mac Conkey agar and parallel suspension in Rappaport-Vassiliadis and Tetrationate broths with posterior streaking in XLT4 agar. The characterization of the isolates was done through biochemical tests and serotyping. Salmonella enterica was found in 17.0% (18/106) of the D. aurita; 50% presented the bacteria in the small intestine (SI), 88.9% in the large intestine (LI) and 66.7% in the cloaca. Of the S. enterica were found the subspecies: diarizonae (11.1%), enterica and houtenae (5.5% each); and the serotypes of the S. enterica enterica were Newport (83.3%), Typhimurium and Cerro (5.5% each). In the D. albiventris 17.5% (7/40) were positive; 42.8% in the SI, 85.7% in the LI and 71.4% in the cloaca. Newport (71.4%) was also the most frequent serotype and the second were Typhimurium, Bareilly and Thompson (14.3% each). The presence of Salmonella enterica in the intestines of opossums in Brazil was proved
On the sensitivity of the HAWC observatory to gamma-ray bursts
We present the sensitivity of HAWC to Gamma Ray Bursts (GRBs). HAWC is a very
high-energy gamma-ray observatory currently under construction in Mexico at an
altitude of 4100 m. It will observe atmospheric air showers via the water
Cherenkov method. HAWC will consist of 300 large water tanks instrumented with
4 photomultipliers each. HAWC has two data acquisition (DAQ) systems. The main
DAQ system reads out coincident signals in the tanks and reconstructs the
direction and energy of individual atmospheric showers. The scaler DAQ counts
the hits in each photomultiplier tube (PMT) in the detector and searches for a
statistical excess over the noise of all PMTs. We show that HAWC has a
realistic opportunity to observe the high-energy power law components of GRBs
that extend at least up to 30 GeV, as it has been observed by Fermi LAT. The
two DAQ systems have an energy threshold that is low enough to observe events
similar to GRB 090510 and GRB 090902b with the characteristics observed by
Fermi LAT. HAWC will provide information about the high-energy spectra of GRBs
which in turn could help to understanding about e-pair attenuation in GRB jets,
extragalactic background light absorption, as well as establishing the highest
energy to which GRBs accelerate particles
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
Altres ajuts: Fondo Europeo de Desarrollo Regional (FEDER), "A way of making Europe".Copy number (CN) polymorphisms of complement C4 play distinct roles in many conditions, including immune-mediated diseases. We investigated the association of C4 CN with systemic sclerosis (SSc) risk. Imputed total C4, C4A, C4B, and HERV-K CN were analyzed in 26,633 individuals and validated in an independent cohort. Our results showed that higher C4 CN confers protection to SSc, and deviations from CN parity of C4A and C4B augmented risk. The protection contributed per copy of C4A and C4B differed by sex. Stronger protection was afforded by C4A in men and by C4B in women. C4 CN correlated well with its gene expression and serum protein levels, and less C4 was detected for both in SSc patients. Conditioned analysis suggests that C4 genetics strongly contributes to the SSc association within the major histocompatibility complex locus and highlights classical alleles and amino acid variants of HLA-DRB1 and HLA-DPB1 as C4-independent signals
Recommended from our members
Ancestral diversity improves discovery and fine-mapping of genetic loci for anthropometric traits - the Hispanic/Latino Anthropometry Consortium
Hispanic/Latinos have been underrepresented in genome-wide association studies (GWAS) for anthropometric traits despite their notable anthropometric variability, ancestry proportions, and high burden of growth stunting and overweight/obesity. To address this knowledge gap, we analyzed densely-imputed genetic data in a sample of Hispanic/Latino adults to identify and fine-map genetic variants associated with body mass index (BMI), height, and BMI-adjusted waist-to-hip ratio (WHRadjBMI). We conducted a GWAS of 18 studies/consortia as part of the Hispanic/Latino Anthropometry (HISLA) Consortium (Stage 1, n=59,771) and generalized our findings in 9 additional studies (HISLA Stage 2, n=10,538). We conducted a trans-ancestral GWAS with summary statistics from HISLA Stage 1 and existing consortia of European and African ancestries. In our HISLA Stage 1+2 analyses, we discovered one BMI locus, as well as two BMI signals and another height signal each within established anthropometric loci. In our trans-ancestral meta-analysis, we discovered three BMI loci, one height locus, and one WHRadjBMI locus. We also identified three secondary signals for BMI, 28 for height, and two for WHRadjBMI in established loci. We show that 336 known BMI, 1,177 known height, and 143 known WHRadjBMI (combined) SNPs demonstrated suggestive transferability (nominal significance and effect estimate directional consistency) in Hispanic/Latino adults. Of these, 36 BMI, 124 height, and 11 WHRadjBMI SNPs were significant after trait-specific Bonferroni correction. Trans-ancestral meta-analysis of the three ancestries showed a small-to-moderate impact of uncorrected population stratification on the resulting effect size estimates. Our findings demonstrate that future studies may also benefit from leveraging diverse ancestries and differences in linkage disequilibrium patterns to discover novel loci and additional signals with less residual population stratification
International nosocomial infection control consortium (INICC) report, data summary of 36 countries, for 2004-2009
The results of a surveillance study conducted by the International Nosocomial Infection Control Consortium (INICC) from January 2004 through December 2009 in 422 intensive care units (ICUs) of 36 countries in Latin America, Asia, Africa, and Europe are reported. During the 6-year study period, using Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN; formerly the National Nosocomial Infection Surveillance system [NNIS]) definitions for device-associated health care-associated infections, we gathered prospective data from 313,008 patients hospitalized in the consortium's ICUs for an aggregate of 2,194,897 ICU bed-days. Despite the fact that the use of devices in the developing countries' ICUs was remarkably similar to that reported in US ICUs in the CDC's NHSN, rates of device-associated nosocomial infection were significantly higher in the ICUs of the INICC hospitals; the pooled rate of central line-associated bloodstream infection in the INICC ICUs of 6.8 per 1,000 central line-days was more than 3-fold higher than the 2.0 per 1,000 central line-days reported in comparable US ICUs. The overall rate of ventilator-associated pneumonia also was far higher (15.8 vs 3.3 per 1,000 ventilator-days), as was the rate of catheter-associated urinary tract infection (6.3 vs. 3.3 per 1,000 catheter-days). Notably, the frequencies of resistance of Pseudomonas aeruginosa isolates to imipenem (47.2% vs 23.0%), Klebsiella pneumoniae isolates to ceftazidime (76.3% vs 27.1%), Escherichia coli isolates to ceftazidime (66.7% vs 8.1%), Staphylococcus aureus isolates to methicillin (84.4% vs 56.8%), were also higher in the consortium's ICUs, and the crude unadjusted excess mortalities of device-related infections ranged from 7.3% (for catheter-associated urinary tract infection) to 15.2% (for ventilator-associated pneumonia). Copyright © 2012 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Abstract
BACKGROUND:
The cardiovascular effects of adding once-weekly treatment with exenatide to usual care in patients with type 2 diabetes are unknown.
METHODS:
We randomly assigned patients with type 2 diabetes, with or without previous cardiovascular disease, to receive subcutaneous injections of extended-release exenatide at a dose of 2 mg or matching placebo once weekly. The primary composite outcome was the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. The coprimary hypotheses were that exenatide, administered once weekly, would be noninferior to placebo with respect to safety and superior to placebo with respect to efficacy.
RESULTS:
In all, 14,752 patients (of whom 10,782 [73.1%] had previous cardiovascular disease) were followed for a median of 3.2 years (interquartile range, 2.2 to 4.4). A primary composite outcome event occurred in 839 of 7356 patients (11.4%; 3.7 events per 100 person-years) in the exenatide group and in 905 of 7396 patients (12.2%; 4.0 events per 100 person-years) in the placebo group (hazard ratio, 0.91; 95% confidence interval [CI], 0.83 to 1.00), with the intention-to-treat analysis indicating that exenatide, administered once weekly, was noninferior to placebo with respect to safety (P<0.001 for noninferiority) but was not superior to placebo with respect to efficacy (P=0.06 for superiority). The rates of death from cardiovascular causes, fatal or nonfatal myocardial infarction, fatal or nonfatal stroke, hospitalization for heart failure, and hospitalization for acute coronary syndrome, and the incidence of acute pancreatitis, pancreatic cancer, medullary thyroid carcinoma, and serious adverse events did not differ significantly between the two groups.
CONCLUSIONS:
Among patients with type 2 diabetes with or without previous cardiovascular disease, the incidence of major adverse cardiovascular events did not differ significantly between patients who received exenatide and those who received placebo. (Funded by Amylin Pharmaceuticals; EXSCEL ClinicalTrials.gov number, NCT01144338 .)